Literature DB >> 10871605

Evidence of a role for SHP-1 in platelet activation by the collagen receptor glycoprotein VI.

J M Pasquet1, L Quek, S Pasquet, A Poole, J R Matthews, C Lowell, S P Watson.   

Abstract

The Src homology (SH)2 domain-containing protein-tyrosine phosphatase SHP-1 is tyrosine phosphorylated in platelets in response to the glycoprotein VI (GPVI)-selective agonist collagen-related peptide (CRP), collagen, and thrombin. Two major unidentified tyrosine-phosphorylated bands of 28 and 32 kDa and a minor band of 130 kDa coprecipitate with SHP-1 in response to all three agonists. Additionally, tyrosine-phosphorylated proteins of 50-55 and 70 kDa specifically associate with SHP-1 following stimulation by CRP and collagen. The tyrosine kinases Lyn, which exists as a 53 and 56-kDa doublet, and Syk were identified as major components of these bands, respectively. Kinase assays on SHP-1 immunoprecipitates performed in the presence of the Src family kinase inhibitor PP1 confirmed the presence of a Src kinase in CRP- but not thrombin-stimulated cells. Lyn, Syk, and SLP-76, along with tyrosine-phosphorylated 28-, 32-, and 130-kDa proteins, bound selectively to a glutathione S-transferase protein encoding the SH2 domains of SHP-1, suggesting that this is the major site of interaction. Platelets isolated from motheaten viable mice (mev/mev) revealed the presence of a heavily tyrosine-phosphorylated 26-kDa protein that was not found in wild-type platelets. CRP-stimulated mev/mev platelets manifested hypophosphorylation of Syk and Lyn and reduced P-selectin expression relative to controls. These observations provide evidence of a functional role for SHP-1 in platelet activation by GPVI.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871605     DOI: 10.1074/jbc.M001531200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Discoidin domain receptor 1 protein is a novel modulator of megakaryocyte-collagen interactions.

Authors:  Vittorio Abbonante; Cristian Gruppi; Diana Rubel; Oliver Gross; Remigio Moratti; Alessandra Balduini
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

2.  A newly identified complex of spinophilin and the tyrosine phosphatase, SHP-1, modulates platelet activation by regulating G protein-dependent signaling.

Authors:  Peisong Ma; Aleksandra Cierniewska; Rachel Signarvic; Marcin Cieslak; Hong Kong; Andrew J Sinnamon; Richard R Neubig; Debra K Newman; Timothy J Stalker; Lawrence F Brass
Journal:  Blood       Date:  2011-12-30       Impact factor: 22.113

3.  Reactive oxygen species play a critical role in collagen-induced platelet activation via SHP-2 oxidation.

Authors:  Ji Yong Jang; Ji Hyun Min; Yun Hee Chae; Jin Young Baek; Su Bin Wang; Su Jin Park; Goo Taeg Oh; Sang-Hak Lee; Ye-Shih Ho; Tong-Shin Chang
Journal:  Antioxid Redox Signal       Date:  2014-01-30       Impact factor: 8.401

4.  CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo.

Authors:  Musaed M Alshahrani; Eunice Yang; Jana Yip; Simona S Ghanem; Simon L Abdallah; Anthony M deAngelis; Cindy J O'Malley; Fatemeh Moheimani; Sonia M Najjar; Denise E Jackson
Journal:  Blood       Date:  2014-08-01       Impact factor: 22.113

5.  Tyrosine phosphorylation on spleen tyrosine kinase (Syk) is differentially regulated in human and murine platelets by protein kinase C isoforms.

Authors:  Lorena Buitrago; Dheeraj Bhavanasi; Carol Dangelmaier; Bhanu Kanth Manne; Rachit Badolia; Alessandra Borgognone; Alexander Y Tsygankov; Steven E McKenzie; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2013-08-19       Impact factor: 5.157

Review 6.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

7.  Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function.

Authors:  Alexandra Mazharian; Jun Mori; Ying-Jie Wang; Silke Heising; Benjamin G Neel; Steve P Watson; Yotis A Senis
Journal:  Blood       Date:  2013-03-18       Impact factor: 22.113

8.  The endothelial tyrosine phosphatase SHP-1 plays an important role for vascular haemostasis in TNFα -induced inflammation in vivo.

Authors:  Elisabeth Koch; Joachim Pircher; Thomas Czermak; Erik Gaitzsch; Stefan Alig; Hanna Mannell; Markus Niemeyer; Florian Krötz; Markus Wörnle
Journal:  Mediators Inflamm       Date:  2013-05-09       Impact factor: 4.711

9.  The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis.

Authors:  Yotis A Senis; Michael G Tomlinson; Stuart Ellison; Alexandra Mazharian; Jenson Lim; Yan Zhao; Kristin N Kornerup; Jocelyn M Auger; Steve G Thomas; Tarvinder Dhanjal; Neena Kalia; Jing W Zhu; Arthur Weiss; Steve P Watson
Journal:  Blood       Date:  2009-02-25       Impact factor: 22.113

10.  Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity.

Authors:  Divya Sagar; Narendra P Singh; Rashida Ginwala; Xiaofang Huang; Ramila Philip; Mitzi Nagarkatti; Prakash Nagarkatti; Konstantin Neumann; Jürgen Ruland; Allison M Andrews; Servio H Ramirez; Zafar K Khan; Pooja Jain
Journal:  Sci Rep       Date:  2017-06-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.